UCBL1,
UMR/CNRS 5822,
Laboratoire de Radiobiologie Cellulaire Moléculaire,
UCBL1, UMR/CNRS 5822, Laboratoire de Radiobiologie Cellulaire Moléculaire
Gersende Alphonse has not added Biography.
If you are Gersende Alphonse and would like to personalize this page please email our Author Liaison for assistance.
Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing.
International journal of cancer. Journal international du cancer Oct, 2002 | Pubmed ID: 12237902
Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels.
Oncogene Apr, 2004 | Pubmed ID: 15048093
Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering.
Free radical biology & medicine Sep, 2007 | Pubmed ID: 17664132
Differential regulation of cell death in head and neck cell carcinoma through alteration of cholesterol levels in lipid rafts microdomains.
Biochemical pharmacology Feb, 2008 | Pubmed ID: 17996216
Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions.
International journal of radiation oncology, biology, physics Jun, 2008 | Pubmed ID: 18234427
Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays.
International journal of radiation oncology, biology, physics May, 2009 | Pubmed ID: 19362238
Targeting a cornerstone of radiation resistance: cancer stem cell.
Cancer letters Sep, 2012 | Pubmed ID: 22459349
Telomere profiling: toward glioblastoma personalized medicine.
Molecular neurobiology Feb, 2013 | Pubmed ID: 23065374
[Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: glioblastoma as an example].
Bulletin du cancer Dec, 2012 | Pubmed ID: 23228708
p53-independent early and late apoptosis is mediated by ceramide after exposure of tumor cells to photon or carbon ion irradiation.
BMC cancer , 2013 | Pubmed ID: 23530619
Targeting Head and Neck Cancer Stem Cells to Overcome Resistance to Photon and Carbon Ion Radiation.
Stem cell reviews Aug, 2013 | Pubmed ID: 23955575
Radiation-enhanced cell migration/invasion process: a review.
Critical reviews in oncology/hematology Nov, 2014 | Pubmed ID: 24908570
[Radiation-induces increased tumor cell aggressiveness of tumors of the glioblastomas?].
Bulletin du cancer Sep, 2014 | Pubmed ID: 25296414
Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma.
Molecular cancer , 2015 | Pubmed ID: 26183089
[Cancer stem cells: Radiotherapeutic features and therapeutic targets].
Bulletin du cancer Jan, 2016 | Pubmed ID: 26702506
[Radiosensitivity and/or radioresistance of head and neck cancers: Biological angle].
Bulletin du cancer Jan, 2016 | Pubmed ID: 26702507
Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives.
World journal of stem cells Jan, 2016 | Pubmed ID: 26839637
Influence of Dose Rate on the Cellular Response to Low- and High-LET Radiations.
Frontiers in oncology , 2016 | Pubmed ID: 27014633
Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC).
Oncotarget Jul, 2016 | Pubmed ID: 27374096
Preclinical models in HNSCC: A comprehensive review.
Oral oncology Feb, 2017 | Pubmed ID: 28109468
Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.
British journal of cancer May, 2017 | Pubmed ID: 28407653
Gadolinium-based nanoparticles as sensitizing agents to carbon ions in head and neck tumor cells.
Nanomedicine : nanotechnology, biology, and medicine Nov, 2017 | Pubmed ID: 28779947
Dual "mAb" HER family blockade in head and neck cancer human cell lines combined with photon therapy.
Scientific reports Sep, 2017 | Pubmed ID: 28939847
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados